Author: Tom Wilemon
Journey Home Project supports first CAR-T infusion at VA hospital
Jan. 16, 2020—The Tennessee Valley Healthcare System performed its first CAR-T infusion recently at the Veterans Administration hospital in Nashville.
ACMG issues statement on breast cancer genetic testing
Jan. 16, 2020—According to a statement on behalf of the American College of Medical Genetics and Genomics, there is insufficient evidence to recommend universal genetic testing for BRCA1/2 alone or in combination with multi-gene panels for all breast cancer patients.
Park named interim Hematology and Oncology director
Jan. 9, 2020—Ben Ho Park, MD, PhD, has been named interim director of the Division of Hematology and Oncology.
Impact of weight gain from early to middle adulthood explored
Jan. 9, 2020—An analysis of weight gain occurring from early to middle adulthood indicates that the added weight is associated with multiple health outcomes in later life.
Richmond receives legacy award from Society for Leukocyte Biology
Dec. 12, 2019—Ann Richmond, PhD, Ingram Professor of Cancer Research, is the 2019 recipient of the Society for Leukocyte Biology Legacy Award.
Balko lands Mary Kay Foundation grant for breast cancer research
Dec. 5, 2019—Vanderbilt-Ingram Cancer Center's Justin Balko, PharmD, PhD, has received a $100,000 research grant from the Mary Kay Foundation.
Study finds breast cancer recurrence score has different implications for men
Nov. 20, 2019—A study published last year offered good news for women with early-stage ER-positive breast cancer who scored at intermediate risk for recurrence. However, a new study finds this conclusion may not directly apply to male patients with the same type of breast cancer
NCI ‘Moonshot’ grant to boost hereditary cancer identification
Nov. 14, 2019—VUMC is leading an initiative to establish a streamlined process for collection of family health histories that could set the stage for a standardized system to make the information easily accessible.
VICC takes leading role in international cancer database project
Nov. 7, 2019—Vanderbilt-Ingram Cancer Center is one of three institutions launching the first phase of a collaboration to advance precision oncology through the creation of a clinico-genomic dataset with an international reach.
Grant bolsters Weiss’ pediatric thyroid cancer research
Nov. 7, 2019—Vivian Weiss, MD, PhD, has been named a 2020 V Scholar and will receive $200,000 from the V Foundation for Cancer Research.
Rathmell receives 2019 Eugene P. Schonfeld Award
Nov. 6, 2019—The Kidney Cancer Association is recognizing the research accomplishments and leadership achievements of W. Kimryn Rathmell, MD, PhD, with its top honor, the Eugene P. Schonfeld Award.
Rathmell lands award from Lupus Research Alliance
Oct. 31, 2019—Jeffrey Rathmell, PhD, is a 2019 recipient of the Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity.
